Portal:ExRNA/FeaturedPathways
From WikiPathways
(Difference between revisions)
(typo) |
(added two new pathways) |
||
| Line 72: | Line 72: | ||
|width=100px|{{#pwimage:Pathway:WP4337|250px||ncRNAs involved in STAT3 signaling in hepatocellular carcinoma}} | |width=100px|{{#pwimage:Pathway:WP4337|250px||ncRNAs involved in STAT3 signaling in hepatocellular carcinoma}} | ||
[http://www.ncbi.nlm.nih.gov/pubmed/28438689 Klingenberg et al. Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets] | [http://www.ncbi.nlm.nih.gov/pubmed/28438689 Klingenberg et al. Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets] | ||
| + | |- | ||
| + | |width=100px|{{#pwimage:Pathway:WP4398|250px||PDGFRα and STMN1 cooperate to exacerbate the cytotoxic effects of vinblastine}} | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/30082792 Jun et al. A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine] | ||
| + | |width=100px|{{#pwimage:Pathway:WP4397|250px||Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors}} | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/29059175 Mitamara et al. Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP)] | ||
| + | |width=100px|{{#pwImage:Pathway:WP1991|250px||SRF and miRs in Smooth Muscle Differentiation and Proliferation}} | ||
| + | |width=100px|{{#pwimage:Pathway:WP2910|250px||Mecp2 and Associated Rett Syndrome}} | ||
|- | |- | ||
|width=100px|{{#pwimage:Pathway:WP673|250px||ErbB Signaling Pathway}} | |width=100px|{{#pwimage:Pathway:WP673|250px||ErbB Signaling Pathway}} | ||
| Line 99: | Line 106: | ||
[http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
|- | |- | ||
| - | |width=100px|{{# | + | |width=100px|{{#pwimage:Pathway:WP2012|250px||miRs in Muscle Cell Differentiation}} |
| - | |width=100px|{{#pwimage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP2029|250px||Cell Differentiation}} |
| + | |width=100px|{{#pwimage:Pathway:WP2261|250px||Signaling Pathways in Glioblastoma}} | ||
|width=100px|{{#pwImage:Pathway:WP2011|250px||REBF and miR33 in cholesterol and lipid homeostasis}} | |width=100px|{{#pwImage:Pathway:WP2011|250px||REBF and miR33 in cholesterol and lipid homeostasis}} | ||
| - | |||
| - | |||
|- | |- | ||
|width=100px|{{#pwImage:Pathway:WP2004|250px||miR-targeted genes in lymphocytes - TarBase}} | |width=100px|{{#pwImage:Pathway:WP2004|250px||miR-targeted genes in lymphocytes - TarBase}} | ||
| Line 116: | Line 122: | ||
|width=100px|{{#pwImage:Pathway:WP2002|250px||miR-targeted genes in epithelium - TarBase}} | |width=100px|{{#pwImage:Pathway:WP2002|250px||miR-targeted genes in epithelium - TarBase}} | ||
[http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
| - | + | |width=100px|{{#pwImage:Pathway:WP1992|250px||TarBasePathway}} | |
| - | |width=100px|{{#pwImage:Pathway: | + | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] |
| - | + | ||
| - | + | ||
|width=100px|{{#pwImage:Pathway:WP2853|250px||Endoderm Differentiation}} | |width=100px|{{#pwImage:Pathway:WP2853|250px||Endoderm Differentiation}} | ||
|width=100px|{{#pwimage:Pathway:WP2858|250px||Ectoderm Differentiation}} | |width=100px|{{#pwimage:Pathway:WP2858|250px||Ectoderm Differentiation}} | ||
| + | |- | ||
|width=100px|{{#pwimage:Pathway:WP2857|250px||Mesodermal Commitment Pathway}} | |width=100px|{{#pwimage:Pathway:WP2857|250px||Mesodermal Commitment Pathway}} | ||
|} | |} | ||
Revision as of 23:32, 19 October 2018
|
Image does not exist T-Cell Receptor and Co-stimulatory Signaling |
Image does not exist IL1 and megakaryotyces in obesity |
Image does not exist RNA interference Ozpolat et al. Liposomal siRNA nanocarriers for cancer therapy Thomas et al. Eri1: a conserved enzyme at the crossroads of multiple RNA-processing pathways |
Image does not exist Extracellular vesicle-mediated signaling in recipient cells |
|
Image does not exist TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer |
Image does not exist mir34a and TGIF2 in osteoclastogenesis |
Image does not exist mir219 in Oligodendrocyte Differentiation and Myelination |
Image does not exist Apoptosis-related network due to altered Notch3 in ovarian cancer |
|
Image does not exist miR-222 in Exercise-Induced Cardiac Growth |
Image does not exist Hypoxia-mediated EMT and Stemness |
Image does not exist DDX1 as a regulatory component of the Drosha microprocessor |
Image does not exist EV release from cardiac cells and their functional effects Danielson and Das, Extracellular Vesicles in Heart Disease: Excitement for the Future? |
|
Image does not exist Rac1/Pak1/p38/MMP-2 pathway Gonzalez-Villasana et al. Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer |
Image does not exist eIF5A regulation in response to inhibition of the nuclear export system Miyake et al. XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A |
Image does not exist MFAP5-mediated ovarian cancer cell motility and invasiveness |
Image does not exist LncRNA-mediated mechanisms of therapeutic resistance Parasramka et al. Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma |
|
Image does not exist ApoE and miR-146 in inflammation and atherosclerosis |
Image does not exist miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma |
Image does not exist mir-124 predicted interactions with cell cycle and differentiation |
Image does not exist miR-517 relationship with ARCN1 and USP1 |
|
Image does not exist miR-509-3p alteration of YAP1/ECM axis |
Image does not exist H19 action Rb-E2F1 signaling and CDK-β-catenin activity |
Image does not exist mir-193a and MVP in colon cancer metastasis Teng et al. H19 MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression |
Image does not exist miRNA regulation of p53 pathway in prostate cancer |
|
Image does not exist miRNA regulation of prostate cancer signaling pathways |
Image does not exist LncRNA involvement in canonical Wnt signaling and colorectal cancer Shen et al. To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer |
Image does not exist Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer |
Image does not exist Extracellular vesicles in the crosstalk of cardiac cells Bei et al. Extracellular Vesicles in Cardiovascular Theranostics. |
|
Image does not exist Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells |
Image does not exist miRNAs in the signaling pathway of the immune response in sepsis Giza et al. Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications |
Image does not exist ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
Image does not exist ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
|
Image does not exist PDGFRα and STMN1 cooperate to exacerbate the cytotoxic effects of vinblastine |
Image does not exist Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors |
Image does not exist SRF and miRs in Smooth Muscle Differentiation and Proliferation |
Image does not exist Mecp2 and Associated Rett Syndrome |
|
Image does not exist ErbB Signaling Pathway |
Image does not exist Mir302-367 Promoting Cardiomyocyte Proliferation |
Image does not exist Alzheimers Disease |
Image does not exist Parkinsons Disease |
|
Image does not exist MicroRNAs in cardiomyocyte hypertrophy |
Image does not exist Integrated Lung Cancer Pathway |
Image does not exist miRNA Biogenesis |
Image does not exist miRNA targets in ECM and membrane receptors |
|
Image does not exist Fluoropyrimidine Activity |
Image does not exist miRNAs involved in DNA damage response |
Image does not exist Metastatic Brain Tumor |
Image does not exist Regulatory RNA pathways |
|
Image does not exist Spinal Cord Injury |
Image does not exist miRNA Regulation of DNA Damage Response |
Image does not exist Parkinsons Disease Pathway (Mus musculus) |
Image does not exist Hepatitis C and Hepatocellular Carcinoma |
|
Image does not exist Metastatic brain tumor |
Image does not exist Role of Osx and miRNAs in tooth development |
Image does not exist miR-127 in mesendoderm differentiation |
Image does not exist miR-targeted genes in adipocytes - TarBase |
|
Image does not exist miRs in Muscle Cell Differentiation |
Image does not exist Cell Differentiation |
Image does not exist Signaling Pathways in Glioblastoma |
Image does not exist REBF and miR33 in cholesterol and lipid homeostasis |
|
Image does not exist miR-targeted genes in lymphocytes - TarBase |
Image does not exist miR-targeted genes in muscle cell - TarBase |
Image does not exist miR-targeted genes in leukocytes - TarBase |
Image does not exist miR-targeted genes in squamous cell - TarBase |
|
Image does not exist miR-targeted genes in epithelium - TarBase |
Image does not exist TarBasePathway |
Image does not exist Endoderm Differentiation |
Image does not exist Ectoderm Differentiation |
|
Image does not exist Mesodermal Commitment Pathway |
